287 related articles for article (PubMed ID: 28124579)
1. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.
Balzer L; Staples P; Onnela JP; DeGruttola V
Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579
[TBL] [Abstract][Full Text] [Related]
2. Adaptive pre-specification in randomized trials with and without pair-matching.
Balzer LB; van der Laan MJ; Petersen ML;
Stat Med; 2016 Nov; 35(25):4528-4545. PubMed ID: 27436797
[TBL] [Abstract][Full Text] [Related]
3. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
Verguet S; Stalcup M; Walsh JA
Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
[TBL] [Abstract][Full Text] [Related]
4. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.
Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM;
Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?
Sidebottom D; Ekström AM; Strömdahl S
BMC Infect Dis; 2018 Nov; 18(1):581. PubMed ID: 30445925
[TBL] [Abstract][Full Text] [Related]
6. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
Fowler N; Arkell P; Abouyannis M; James C; Roberts L
AIDS Patient Care STDS; 2015 Jan; 29(1):33-42. PubMed ID: 25375792
[TBL] [Abstract][Full Text] [Related]
7. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
Nikolopoulos GK; Christaki E; Paraskevis D; Bonovas S
Curr Pharm Des; 2017; 23(18):2579-2591. PubMed ID: 28356043
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa.
Perriat D; Balzer L; Hayes R; Lockman S; Walsh F; Ayles H; Floyd S; Havlir D; Kamya M; Lebelonyane R; Mills LA; Okello V; Petersen M; Pillay D; Sabapathy K; Wirth K; Orne-Gliemann J; Dabis F;
J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29314658
[TBL] [Abstract][Full Text] [Related]
9. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
Mabileau G; Schwarzinger M; Flores J; Patrat C; Luton D; Epelboin S; Mandelbrot L; Matheron S; Yazdanpanah Y
Am J Obstet Gynecol; 2015 Sep; 213(3):341.e1-12. PubMed ID: 25979615
[TBL] [Abstract][Full Text] [Related]
10. The impact of nurse-driven targeted HIV screening in 8 emergency departments: study protocol for the DICI-VIH cluster-randomized two-period crossover trial.
Leblanc J; Rousseau A; Hejblum G; Durand-Zaleski I; de Truchis P; Lert F; Costagliola D; Simon T; Crémieux AC
BMC Infect Dis; 2016 Feb; 16():51. PubMed ID: 26831332
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
[TBL] [Abstract][Full Text] [Related]
12. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of trans women in pre-exposure prophylaxis trials: a review.
Escudero DJ; Kerr T; Operario D; Socías ME; Sued O; Marshall BD
AIDS Care; 2015; 27(5):637-41. PubMed ID: 25430940
[TBL] [Abstract][Full Text] [Related]
14. Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings.
Rudolph JE; Cole SR; Eron JJ; Kashuba AD; Adimora AA
Epidemiology; 2019 May; 30(3):358-364. PubMed ID: 30640216
[TBL] [Abstract][Full Text] [Related]
15. What is the place of pre-exposure prophylaxis in HIV prevention?
De Man J; Colebunders R; Florence E; Laga M; Kenyon C
AIDS Rev; 2013; 15(2):102-11. PubMed ID: 23685443
[TBL] [Abstract][Full Text] [Related]
16. Leveraging contact network structure in the design of cluster randomized trials.
Harling G; Wang R; Onnela JP; De Gruttola V
Clin Trials; 2017 Feb; 14(1):37-47. PubMed ID: 27798376
[TBL] [Abstract][Full Text] [Related]
17. Adaptive pair-matching in randomized trials with unbiased and efficient effect estimation.
Balzer LB; Petersen ML; van der Laan MJ;
Stat Med; 2015 Mar; 34(6):999-1011. PubMed ID: 25421503
[TBL] [Abstract][Full Text] [Related]
18. Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials.
Mitchell KM; Dimitrov D; Hughes JP; Moore M; Vittinghoff E; Liu A; Cohen MS; Beyrer C; Donnell D; Boily MC
Epidemics; 2020 Dec; 33():100423. PubMed ID: 33285419
[TBL] [Abstract][Full Text] [Related]
19. Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.
Kabami J; Koss CA; Sunday H; Biira E; Nyabuti M; Balzer LB; Gupta S; Chamie G; Ayieko J; Kakande E; Bacon MC; Havlir D; Kamya MR; Petersen M;
J Acquir Immune Defic Syndr; 2024 Apr; 95(5):447-455. PubMed ID: 38489493
[TBL] [Abstract][Full Text] [Related]
20. Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials.
Jiang J; Yang X; Ye L; Zhou B; Ning C; Huang J; Liang B; Zhong X; Huang A; Tao R; Cao C; Chen H; Liang H
PLoS One; 2014; 9(2):e87674. PubMed ID: 24498350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
